Citation: J. Masuda et al., Silent stroke: pathogenesis, genetic factors and clinical implications as a risk factor, CURR OP NEU, 14(1), 2001, pp. 77-82
Authors:
Morita, M
Kita, Y
Morikawa, N
Iwami, M
Notsu, Y
Citation: M. Morita et al., Expression of arginine vasopressin and vasopressin V-1a receptor mRNA in diabetic (db/db) mice, EXP CL E D, 109(5), 2001, pp. 261-266
Authors:
Suzuki, A
Yasuno, T
Kojo, H
Hirosumi, J
Mutoh, S
Notsu, Y
Citation: A. Suzuki et al., Alteration in expression profiles of a series of diabetes-related genes indb/db mice following treatment with thiazolidinediones, JPN J PHARM, 84(2), 2000, pp. 113-123
Authors:
Park, HY
Nabika, T
Notsu, Y
Kobayashi, S
Masuda, J
Citation: Hy. Park et al., Effects of apolipoprotein A gene polymorphisms on lipoprotein (a) concentrations in Japanese, CLIN EXP PH, 26(4), 1999, pp. 304-308
Authors:
Aramori, I
Zenkoh, J
Morikawa, N
Asano, M
Hatori, C
Sawai, H
Kayakiri, H
Satoh, S
Inoue, T
Abe, Y
Sawada, Y
Mizutani, T
Inamura, N
Iwami, M
Nakahara, K
Kojo, H
Oku, T
Notsu, Y
Citation: I. Aramori et al., Nonpeptide mimic of bradykinin with long-acting properties, IMMUNOPHARM, 45(1-3), 1999, pp. 185-190